Sponsor or institution
Clinical trials and research at Prokaryotics, INC.
As of November 12, 2026, Find a Trial lists 8 NIH-funded research projects at this institution, with $5.0 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 8NIH research projects
NIH-funded research (8)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Synergistic adjuvant with a novel antibiotic to treat Acinetobacter baumannii infections
A new combination approach aims to use a polymyxin helper with a novel antibiotic to fight hard-to-treat Acinetobacter infections in patients.
-
Antifungal drugs targeting the fungal Mcd4 enzyme
Developing a new antifungal medicine that blocks a fungal enzyme to help people with serious infections like bloodstream Candida, invasive Aspergillus, and drug-resistant C. auris.
-
New antibiotic that blocks how Gram-negative bacteria build their outer membrane
Testing a new IV and oral antibiotic aimed at treating urinary and other infections caused by drug-resistant Gram-negative bacteria like CRE.
-
Creating a new treatment to enhance the effectiveness of polymyxin antibiotics against resistant bacterial infections.
This study is testing a new treatment that combines a special antibiotic called medinamycin with polymyxin antibiotics to help people with tough infections caused by a bacteria called Acinetobacter baumannii, which is hard to treat with regular antibiotics.
-
Developing new antifungal drugs to combat resistant infections
This study is working on new antifungal medicines that target a specific part of certain harmful fungi, like Aspergillus and Candida, to help fight infections, especially as some fungi are becoming harder to treat.
-
Creating a new antibiotic to fight superbugs causing severe infections
This study is working on a new antibiotic to help fight tough infections caused by superbugs called Carbapenem-resistant Enterobacteriaceae (CRE), which can make urinary tract infections hard to treat, especially when other medicines don’t work anymore.
-
Developing a new antifungal treatment for drug-resistant infections
This study is working on a new treatment for tough fungal infections caused by Candida and Aspergillus that don't respond to current medications, aiming to help patients who have few options left.
-
Developing a new oral treatment for drug-resistant bacterial infections
This study is testing a new oral medication that combines innovative compounds with traditional antibiotics to help treat stubborn infections caused by certain bacteria, making it easier and safer for patients to get the care they need.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.